Belfast, Northern Ireland-based Intelesens has received FDA 510(k) clearance for its wearable vital signs monitor, called zensor, designed for monitoring patients outside the hospital.
“This is a significant milestone for Intelesens and zensor," Intelesens Commercial Manager Stephen Henderson said in a statement. "...Not only does FDA clearance give the company access to the world’s biggest...
Intelesens's Zensor device.
Scanadu and Intelesens (makers of the Zensor device), two of the ten finalists for the Qualcomm Tricorder X Prize, have merged their teams into one as the competition enters the home stretch. It wraps up in 2016.
"Intelesens and Scanadu have been working together informally for a while," Shannon Wolf Montague, Commercial Manager at Intelesense, told MobiHealthNews...
Ireland-based Intelesens received FDA 510(k) clearance last month for its Aingeal wearable wireless hospital monitor, which passively monitors various vital signs.
According to the company, Aingeal differentiates itself from competitors in that it "measures the patient's ECG, heart rate, temperature and motion and sends that information wirelessly so that it is immediately and easily accessible...
